By Gia Velasquez – Edited by Yunnan Jiang
New Jersey Bill Seeks to Ban Texting While Walking
Though 46 states have banned texting while driving, New Jersey Assemblywoman Pamela Lampitt introduced a bill that seeks to extend the texting ban to pedestrians. Since a 2013 nationwide study at The Ohio State University reported 1,500 emergency room visits in 2010 for injuries sustained texting while walking, the problem has grown. Though a recent survey reported 78 percent of adults agree distracted walking is a serious problem, 49 percent believe they do “not at all” text, read emails/websites, play games, or take selfies. If passed, violators of the texting while walking statute could be fined up to $50 or imprisoned.
“Unreasonable” Behavior During Litigation Cost Video Website $30,000
In September 2015, Garfum.com, a small video website, claimed a Pennsylvania photographer infringed on their patent, entitled “Method of sharing multi-media content among users in a global computer network” by hosting photo contests on her website, Bytephoto. The Electronic Frontier Foundation (EFF) took on Ruth Taylor’s case pro bono, and Garfum.com dropped the case. The EFF then sued Garfum.com for attorney’s fees, for which a New Jersey District Court has awarded Taylor $30,000. U.S. Chief District Judge Jerome Simandle found Garfum.com’s conduct during litigation was “unreasonable” and that the suit was brought in bad faith.
California Medical Device Company Fails to Meet Internal Standards
Theranos, Inc., a California-based medical testing company, is under scrutiny after a 121-page report issued by the Centers for Medicare and Medicaid Services (CMS) showed the company failed to meet their own internal standards regarding the accuracy of their Edison testing device. Valued at $9 billion in February 2014, Theranos promised only a few finger pricks could produce results for over 200 medical tests. CMS showed that 29% of the quality-control checks fell short of the expectations set forth by Theranos. Theranos responded to the report by “proactively suspending testing associated with any affected areas last year after learning of the issues” and planning to hire a new full-time lab director.